OPRK1 and irritable bowel syndrome: Emerging evidence also suggests that KOR contributes to the regulation of visceral hypersensitivity, a core pathological feature of irritable bowel syndrome (IBS) (Chey et al., 2015); however, clinical data on KOR-selective agonists in IBS remain limited.